Palavras-chave
Capacidade funcional
Força muscular
Calcidiol
Como Citar
Resumo
Introdução: A vitamina D tem efeitos benéficos que supostamente contribuem para a manutenção da função músculo-esquelética.
Objetivo: Analisar em uma população não selecionada o efeito dos níveis de calcidiol na função muscular de ambas as mãos, nas atividades da vida diária e nas alterações na densidade mineral óssea (DMO).
Material e métodos: Utilizou-se a coorte do estudo EVOS, que realizou, entre outras, medidas de força muscular de preensão nas duas mãos, questões relacionadas à dificuldade na realização das atividades diárias, estudo densitométrico da coluna lombar e quadril e bioquímica para determinação dos níveis de calcidiol.
Resultados: Valores de calcidiol ≥20 ng / mL foram associados ao aumento da força muscular de preensão em ambas as mãos. Após o ajuste para idade, sexo, IMC e sazonalidade, os níveis de calcidiol <20 ng / mL foram associados de forma independente à diminuição da força de preensão muscular apenas na mão esquerda (OR = 2,35, IC 95% 1,03-5, 38) Da mesma forma, a incapacidade ou dificuldade em "pegar um livro ou objeto em uma prateleira alta" e "sair da cama" foi significativamente associada a níveis de calcidiol <20 ng / mL. Níveis de calcidiol <20 ng / mL foram associados a maiores perdas de DMO no colo do fêmur e no quadril total. Essas associações foram mantidas na análise multivariada.
Conclusões: A manutenção de níveis de calcidiol ≥20 ng / mL foi associada a maior força de preensão muscular nas mãos, manutenção das atividades diárias e menor perda de DMO no quadril. Este estudo corrobora a utilidade de manter níveis adequados de vitamina D para manter a função músculo-esquelética.
Referências
Cederholm T, Cruz-Jentoft AJ, Maggi S. Sarcopenia and fragility fractures. Eur J Phys Rehabil Med. 2013;49:111-7.
Rizzoli R, Stevenson JC, Bauer JM, van Loon LJ, Walrand S, Kanis JA, et al. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas. 2014;79:122-32.
Morgan KT. Nutritional determinants of bone health. J Nutr Elder. 2008;27:3-27.
Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011;25:585-91.
Bischoff-Ferrari HA. Relevance of vitamin D in muscle health. Rev Endocr Metab Disord. 2012;13:71
Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6:847-58.
Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4-8.
Tieland M, Brouwer-Brolsma EM, Nienaber-Rousseau C, van Loon LJ, de Groot LC. Low vitamin D status is associated with reduced muscle mass and impaired physical performance in frail elderly people. Eur J Clin Nutr. 2013;67:1050-5.
Bischoff HA, Stahelin HB, Urscheler N, Ehrsam R, Vonthein R, Perrig-Chiello P, et al. Muscle strength in the elderly: Its relation to vitamin D metabolites. Arch Phys Med Rehabil. 1999;80:54-8.
Zamboni M, Zoico E, Tosoni P, Zivelonghi A, Bortolani A, Maggi S, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol A Biol Sci Med Sci. 2002;57:M7-11.
Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007;92:2058-65.
Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P. VitaminD status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab. 2006;91:2980-5.
Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: A systematic review and meta-analysis. Osteoporos Int. 2011;22:859-71.
Howard GA, Turner RT, Sherrard DJ, Baylink DJ. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1, 25-dihydroxyvitamin D3 and 24, 25-dihydroxyvitamin D3. J Biol Chem. 1981;256:7738-40.
van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, et al. Evidence for auto/paracrine actions of vitamin D in bone: 1ahydroxylase expression and activity in human bone cells. FASEB J. 2006;20:2417-9.
Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, et al. Metabolism of vitamin D3 in human osteoblasts: Evidence for autocrine and paracrine activities of 1a, 25-dihydroxyvitamin D3. Bone. 2007;40:1517-28.
van der Meijden K, Lips P, van Driel M, Heijboer AC, Schulten EA, den Heijer M, et al. Primary human osteoblasts in response to 25-Hydroxyvitamin D3, 1, 25-Dihydroxyvitamin D3 and 24R, 25-Dihydroxyvitamin D3. PLoS ONE. 2014;9:e110283.
Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Human prostate cells synthesize 1, 25-dihydroxyvitaminD3 from 25-hydroxyvitaminD3. Cancer Epidemiol Biomarkers Prev. 1998;7:391-5.
Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, et al. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25- dihydroxyvitamin D in human monocytes. J Bone Miner Res. 2013;28:46-55.
O´Neill TW, Cooper C, Algra D, Pols HAP, Agnusdei D, Dequeker J, et al, on behalf of the European Vertebral Osteoporosis Study Group. Design and development of a questionnaire for use in a multicentre study of vertebral osteoporosis in Europe: The European vertebral osteoporosis study (EVOS). Rheumatol Eur. 1995;24:75-81.
O'Neill TW, Cooper C, Cannata JB, Diaz Lopez JB, Hoszowski K, Johnell O, et al, on behalf of the European Vertebral Osteoporosis Study (EVOS) Group. Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: the European Vertebral Osteoporosis Study. Int J Epidemiol. 1994;23:559-65.
Gómez Alonso C. Valores de la densidad mineral ósea (BMD) en columna lumbar y cadera de la población sana española. En: Díaz Curiel M, Díez Pérez A, Gómez Alonso C, FHOEMO-SEIOMM-RPR (eds). Nuevas fronteras en el estudio de la densidad ósea en la población española. Madrid: Rhone Poulenc Rorer; 1996. p. 73-94.
Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013;34:33-83.
Barbonetti A, D´Andrea S, Martorella A, Felzani G, Francavilla S, Francavilla F. Low vitamin D levels are independent predictors of 1-year worsening in physical function in people with chronic spinal cord injury: a longitudinal study. Spinal Cord. 2018;56:494-501.
Nicoletti Gumieiro D, Murino Rafacho BP, Buzati Pereira BL, Alvisi Cavallari K, Erico Tanni S, Schmidt Azevedo P, et al. Vitamin D serum levels are associated with handgrip strength but not with muscle mass or length of hospital stay after hip fracture. Nutrition. 2015;31:931-4.
Visser M, Deeg DJH, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88:5766 e 5772.
Arbex Borim FS, da Silva Alexandre T, Liberalesso Neri A, de Oliveira Máximo R, Fernandes Silva M, de Oliveira C. Combined effect of dynapenia (muscle weakness) and low vitamin D status on incident disability. J Am Med Dir Assoc. 2019;20:47-52.
Sohl E, van Schoor NM, de Jongh RT, Visser M, Deeg DJH, Lips P. Vitamin D status is associated with functional limitations and functional decline in older individuals. J Clin Endocrinol Metab. 2013;98:E1483-90.
Verreault R, Semba RD, Volpato S, Ferrucci L, Fried LP, Guralnik JM. Low serum vitamin D does not predict new disability or loss of muscle strength in older women. J Am Geriatr Soc. 2002;50: 912-7.
Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116:634-9.
Reid IR, Bolland MJ, Grey A. Effects of 2014 vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2014;383:146-55.
Montoya MJ, Vázquez MA, Miranda C, Miranda MJ, Pérez-Cano R, Giner M. Influencia de la vitamina D sobre la microestructura y propiedades biomecánicas de pacientes con fractura de cadera. Rev Osteoporos Metab Miner. 2017;9:121-9.
Gómez C, Naves ML, Barrios Y, Díaz JB, Fernández JL, Salido E, et al. Vitamin D receptor gene polymorphisms, bone mass, bone loss and prevalence of vertebral fracture: differences in postmenopausal women and men. Osteoporos Int. 1999;10:175-82.
Naves M, Díaz-López JB, Gómez C, Rodríguez-Rebollar A, Rodríguez-García M, Cannata-Andía JB. The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population. Osteoporos Int. 2003;14:520-4.
Naves M, Díaz-López JB, Gómez C, Rodríguez-Rebollar A, Serrano-Arias M, Cannata-Andía JB. Prevalence of osteoporosis in men and determinants of changes in bone mass in a non-selected Spanish population. Osteoporos Int. 2005;16:603-9.
Naves M, Díaz-López JB, Gómez C, Rodríguez-Rebollar A, Cannata-Andía JB. Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50. Osteoporos Int. 2005;16:2013-7.
Naves M, Rodríguez-García M, Díaz-López JB, Gómez-Alonso C, Cannata-Andía JB. Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int. 2008;19:1161-6.
Naves-Díaz M, Cabezas-Rodríguez I, Barrio-Vázquez S, Fernández E, Díaz-López JB, Cannata-Andía JB. Low calcidiol levels and risk of progression of aortic calcification. Osteoporos Int. 2012;23:1177-82.
Tuñón-Le Poultel D, Cannata-Andía JB, Román-García P, Díaz-López JB, Coto E, Gómez C, et al. Association of matrix Gla protein gene functional polymorphisms with loss of bone mineral density and progression of aortic calcification. Osteoporos Int. 2014;25:1237-46.
Este artigo é uma cópia com adaptação para o português do Artigo Original "Gómez Alonso, C., et al. "Niveles de calcidiol y mantenimiento de la función muscular, capacidad funcional y densidad mineral ósea en población española no seleccionada." Revista de Osteoporosis y Metabolismo Mineral 11.1 (2019): 6-11." Esta Cópia com adaptação para o Português segue os preceitos Creative Commons CC BY 4.0 ( https://creativecommons.org/licenses/by/4.0/deed.pt_BR ) disponibilizado pelo periódico responsável pela publicação original ( http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1889-836X2019000100002&lng=es&nrm=iso&tlng=es ).
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2019 Autores